14th Vaccine Congress – Online Edition
Combatting the threat of Covid-19
Online | 28-29 September 2020
Free online conference to help the vaccine community in the fight against Covid-19
Dan Barouch, Centre for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, USA
Sarah Gilbert, University of Oxford, UK
Barney Graham, NIAID Vaccine Research Center, USA
Paul Klenerman, University of Oxford, UK
Heidi Larson, London School of Hygiene & Tropical Medicine, UK
Giovanni Rezza, Director of the Department of Infectious Diseases at the Istituto Superiore di Sanità, Roma, Italy
We invite you to join us online on the 28-29 September 2020 for the 14th Vaccine Congress – Online Edition: Combatting the threat of Covid-19
We are pleased to announce that we are developing the 14th Vaccine Congress into a FREE online event, enabling us to provide wider access to the research development on Covid-19 during this time of crisis. The congress will take place online from 28-29 September 2020 and will be available afterwards on demand.
The focus will be on combatting the threat of Covid-19, with leading experts in vaccinology sharing their knowledge on the current developments and challenges we face.
The Congress is organized by Vaccine, the premier journal for those interested in vaccine science and will be chaired by Gregory A. Poland, Editor in Chief, Vaccine and Mayo Clinic, USA.
By attending you will gain a unique insight into the latest discoveries and challenges this worldwide crisis presents, as well as a highly valuable opportunity to connect with world experts in the global vaccine community.
You will also have the opportunity to exchange knowledge with colleagues from all over the world by uploading a pdf poster of your research online.
Gregory A. Poland, Editor in Chief, Vaccine and Mayo Clinic, USA
Paolo Bonanni, University of Florence, Italy
- Covid immunology
- Vaccine platforms
- Focus on the 2-3 frontrunner vaccines
- Age based versus risk based vaccination
- Enhancing vaccine immunogenicity – Adjuvants, modifiers and antigen packaging
- Fungal, bacterial, AMR vaccines
- Hot topics
- Novel and emerging influenza vaccines
- Research funding for vaccine research – What is the future?
- Systems vaccinology and big data
- Vaccines against emerging diseases A – Current progress (Chikungunya, Zika, Dengue)
- Vaccines against emerging diseases B – Current progress (Ebola, Nipah, Coronavirus, Other)
- Vaccines against neurological infections
- Vaccines against non-communicable diseases (Cancer, Allergy, Other)
- Vaccines against spirochetal diseases (Lyme, Syphilis, Leptospirosis, Other)
- Vaccine durability (Measles, Mumps, Pertussis)
- Vaccine hesitancy and population coverage rates
- Veterinary vaccinology